Multiple-day administration of fosaprepitant combined with tropisetron and olanzapine improves the prevention of nausea and vomiting in patients receiving chemotherapy prior to autologous hematopoietic stem cell transplant: a retrospective study

Chemotherapy-induced nausea and vomiting (CINV) is common in patients with lymphoma and multiple myeloma (MM) receiving high-dose chemotherapy (HDC) followed by autologous stem cell transplantation (ASCT). Despite a standard triple antiemetic regimen of a neurokinin-1 (NK1) receptor antagonist (RA),...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of hematology 2022-08, Vol.101 (8), p.1835-1841
Hauptverfasser:	Ye, Peipei, Pei, Renzhi, Wang, Tiantian, Cao, Junjie, Zhang, Pisheng, Chen, Dong, Liu, Xuhui, Du, Xiaohong, Li, Shuangyue, Tang, Shanhao, Hu, Youqian, Jiang, Lei, Lu, Ying
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiemetics Antipsychotics Chemotherapy Hematology Lymphoma Medicine Medicine & Public Health Oncology Original Article Stem cell transplantation Stem cells Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!